Pharmafile Logo
Pharmafocus logo
Advanced Search
920x920

Judge overseeing Purdue Pharma bankruptcy approves $1.3 million bonus for CEO

January 27, 2020
Sales and Marketing Election 2020, OxyContin, Purdue Pharma, US Presidential Race, fentanyl, opioid crisis

Purdue Pharma’s CEO Craig Landau can receive a $1.3 million bonus, ruled a judge. Judge Robert Drain said the company …

News
top_10_image_43

Top Ten most popular articles on Pharmafile.com this week

January 24, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Indian pharmaceutical firms received more than double the amount of warning letters in the first ten months of 2019, compared …

News
janssen_latest_logo_on_sign_closer

European Commission expands Stelara for paediatric moderate to severe plaque psoriasis

January 24, 2020
Research and Development Europe, Janssen, Stelara, pharma

Janssen’s Stelara (ustekinumab) has seen its label expanded in Europe to include the treatment of moderate to severe plaque psoriasis …

News
chandler-01

FDA puts MDMA therapy for PTSD on its Expanded Access program

January 24, 2020
Medical Communications Expanded Access, MAPS, MDMA, PTSD, pharmaceuticals, psychedelics, war

The FDA has made MDMA treatment for PTSD more accessible by putting it on the Expanded Access program. 10 sites …

News

Roche’s Tecentriq falls short as an adjuvant monotherapy in muscle-invasive urothelial cancer

January 24, 2020
Medical Communications, Sales and Marketing Cancer, Roche, pharma, tecentriq, trial failure

Roche has released an update on the development of its immunology Tecentriq (atezolizumab), making it known that the drug failed …

News
woman-wearing-mouth-mask

UK tests 14 people for Chinese coronavirus

January 24, 2020
Medical Communications Chinese Coronavirus, NHS, Public Health England, Viral outbreaks, Viral pnemonia, coronavirus, epidemic

14 people in the UK have been tested for the Chinese coronavirus, according to Public Health England (PHE). In Scotland, …

News
shutterstock_92671375

Former Insys sales exec sentenced to a year in prison for offering lap dances to encourage fentanyl spray prescriptions

January 23, 2020
Medical Communications, Sales and Marketing insys, pharma

A sales executive at the disgraced and bankrupted firm Insys who was accused of offering lap dances in order to …

News
shutterstock_95714119

Oxford Immunotec to supply TB diagnostic tests to china to aid in coronavirus crisis

January 23, 2020
Medical Communications, Sales and Marketing China, Oxford Immunotec Global, Wuhan, coronavirus, pharma

As fears rise over the impact and spread of Chinese coronavirus following news of a rising death toll and the …

News

NICE declines to recommend Astellas’ Xospata in rlapsed/refractory FLT3+ acute myeloid leukaemia

January 23, 2020
Sales and Marketing Astellas, NHS, NICE, UK, Xospata, acute myeloid leukaemia

The latest in a series of rejections over the past week, NICE has revealed that it has knocked back the …

News
roche__tree

Roche’s risdiplam hits main goal in infants with spinal muscular atrophy

January 23, 2020
Research and Development Roche, pharma, risdiplam, spinal muscular atrophy

Roche has announced the success of its survival motor neuron-2 (SMN2) splicing modifier risdiplam in a new trial investigating its …

News

China approves Roche cancer drug Kadcyla

January 22, 2020
Business Services China, Roche, breast cancer, cancer treatment, oncology

China has approved the import of Roche’s drug for breast cancer, just after it recently won expanded approval in the …

News
5204602349_c87b204860_b

FDA fast-tracks GSK’s multiple myeloma drug after priority review

January 22, 2020
Research and Development BCMA, FDA, GSK, Phase 2 Trials, Phase Trials, multiple myeloma, myeloma

The FDA has fast tracked GlaxoSmithKline (GSK) antibody drug conjugate (ADC) belantamab mafodotin, for the treatment of patients with refractory …

News
fda2outsideweb

Horizon’s Tepezza becomes first and only FDA-approved drug for thyroid eye disorder

January 22, 2020
Research and Development FDA, Horizon Therapeutics, Tepezza, pharma

Horizon Therapeutics has announced that its IGF-1R inhibitor Tepezza (teprotumumab-trbw) has become the first and only therapy approved by the …

News
mask-1954673_1280

Chinese coronavirus set to be put on international health emergency list

January 22, 2020
Research and Development Ebola, Public Health Emergency, WHO, World Health Organisation, Wuhan, polio, swine flu

The World Health Organisation (WHO) is expected to trigger a Public Health Emergency over the Wuhan coronavirus outbreak, meaning it …

News

No NICE recommendation for AstraZeneca’s Tagrisso in EGFR+ lung cancer

January 22, 2020
Research and Development, Sales and Marketing AstraZeneca, NICE, Tagrisso, pharma

AstraZeneca’s Tagrisso (osimertinib) has been knocked back for routine use on the NHS in England and Wales by the drug …

News

Novartis establishes its new legal entity in Vietnam

January 22, 2020
Research and Development Novartis, Novartis Vietnam, oncology, pharma

Novartis has inaugurated its new legal entity in Vietnam, Novartis Vietnam Co Ltd, and has become one of the first …

News
roche__tree

EU approval for Roche’s Polivy combo in relapsed/refractory B-cell lymphoma

January 21, 2020
Manufacturing and Production, Sales and Marketing Cancer, Polivy, Roche, lymphoma, pharma

The European Commission has awarded conditional marketing approval to Roche’s Polivy (polatuzumab vedotin), it has been revealed.

News

Janssen’s ulcerative colitis medicine not recommended by NICE for use in adults

January 21, 2020
Manufacturing and Production IBS, Irrated Bowels, NHS, NICE, bowel, ulcerative colitis

NICE has published draft guidance which does not recommend Stelara (ustekinumab) for treating moderately to severely active ulcerative colitis in …

News
jazz_pharma

Jazz Pharma’s Sunosi becomes first EU-approved drug of its kind in narcolepsy and sleep apnoea

January 21, 2020
Manufacturing and Production, Sales and Marketing jazz pharmaceuticals, narcolepsy, pharma

Jazz Pharmaceuticals has secured approval from the European Commission for Sunosi (solriamfetol), it has emerged, as a therapy to improve …

News
29419203133_3c3c14e63e_z

Cardiff University team discovers new method of killing cancers

January 21, 2020
Manufacturing and Production Cancer, Cancer cures, Cancerous, Cardiff University, T cell, cells, immune system, immunity, t-cell

A team at Cardiff University have discovered a new part of the human immune system that could be harnessed to …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026